HYPORENINEMIC HYPOALDOSTERONISM, SODIUM WASTING AND MINERALOCORTICOID-RESISTANT HYPERKALEMIA IN 2 PATIENTS WITH OBSTRUCTIVE UROPATHY

被引：8
|
作者：
PELLEYA, R [1 ]
OSTER, JR [1 ]
PEREZ, GO [1 ]
机构：
[1] VET ADM MED CTR,MED SERV,DIALYSIS UNIT IIIC,MIAMI,FL 33125
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 1983年 / 3卷 / 04期
关键词：
D O I：
10.1159/000166717
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 227
页数：5
相关论文
共 50 条
  • [21] Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients
    Morita, Ryutaro
    Tsukamoto, Shunichiro
    Obata, Shota
    Yamada, Takayuki
    Uneda, Kazushi
    Uehara, Tatsuki
    Rehman, Muhammad Ebad
    Azushima, Kengo
    Wakui, Hiromichi
    Tamura, Kouichi
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1271 - 1279
  • [22] Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes
    Sawada, Kei
    Karashima, Shigehiro
    Kometani, Mitsuhiro
    Oka, Rie
    Takeda, Yoshimichi
    Sawamura, Toshitaka
    Fujimoto, Aya
    Demura, Masashi
    Wakayama, Ayako
    Usukura, Mikiya
    Yagi, Kunimasa
    Takeda, Yoshiyu
    Yoneda, Takashi
    ENDOCRINE JOURNAL, 2018, 65 (04) : 461 - 467
  • [23] Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study
    Naoki Kashihara
    Toshiki Nishio
    Takeshi Osonoi
    Yosuke Saka
    Toshiyuki Imasawa
    Takayasu Ohtake
    Hiroshi Mizuno
    Yugo Shibagaki
    Hyosung Kim
    Toshitaka Yajima
    Nobuaki Sarai
    Clinical and Experimental Nephrology, 2020, 24 : 1144 - 1153
  • [24] THE EFFECT OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS, MINERALOCORTICOID RECEPTOR ANTAGONISTS, AND ITS COMBINATION ON ALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY
    Morita, Ryutaro
    Tsukamoto, Shunichiro
    Obata, Shota
    Yamada, Takayuki
    Rehman, Muhammad
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S81 - S82
  • [25] Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study
    Kashihara, Naoki
    Nishio, Toshiki
    Osonoi, Takeshi
    Saka, Yosuke
    Imasawa, Toshiyuki
    Ohtake, Takayasu
    Mizuno, Hiroshi
    Shibagaki, Yugo
    Kim, Hyosung
    Yajima, Toshitaka
    Sarai, Nobuaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (12) : 1144 - 1153
  • [26] The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
    Provenzano, Michele
    Jongs, Niels
    Vart, Priya
    Stefansson, Bergur, V
    Chertow, Glenn M.
    Langkilde, Anna Maria
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, C. David
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (03): : 436 - 443
  • [27] The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension
    Thangaraj, Sai Sindhu
    Oxlund, Christina Stolzenburg
    Da Fonseca, Micaella Pereira
    Svenningsen, Per
    Stubbe, Jane
    Palarasah, Yaseelan
    Ketelhuth, Daniel F. J.
    Jacobsen, Ib. Abildgaard
    Jensen, Boye L.
    JOURNAL OF HYPERTENSION, 2022, 40 (01) : 153 - 162
  • [28] Cost Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Compared with Mineralocorticoid Receptor Antagonists among Patients with Heart Failure and a Reduced Ejection Fraction
    Guo, Jingchaun
    Petersen, Matthew R.
    Tang, Huilin
    Meece, Lauren E.
    Shao, Hui
    Ahmed, Mustafa M.
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)
  • [29] Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and theircombination on albuminuria in diabetic patients(vol 25, pg 1271, 2023)
    Morita, R.
    Tsukamoto, S.
    Obata, S.
    DIABETES OBESITY & METABOLISM, 2023,
  • [30] A RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF THE EFFECTS OF 12 WEEKS OF SODIUM ZIRCONIUM CYCLOSILICATE (SZC) ON ALBUMINURIA (UACR) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERKALEMIA
    Persson, Frederik
    Heinrich, Niels Sondergaard
    Borg, Rikke
    Hellberg, Olof
    Anders, Fernstro Spacing Diaeresis M.
    Furuland, Hans
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1340 - 1340
12345